We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Proteasome Blocker Brings Glaucoma Gene Therapy Closer

News   Jan 17, 2018 | Original Story from the University of Wisconsin-Madison

 
Proteasome Blocker Brings Glaucoma Gene Therapy Closer

To improve gene transfer to treat the blinding disease glaucoma, the front of an untreated eye (left) is compared to an eye (right) pre-treated with a gene delivery enhancer. The green marker reveals the expression of the gene introduced through gene therapy, showing improved delivery using the enhancer. Credit: Curtis Brandt/Paul Kaufman, University of Wisconsin-Madison

 
 
 

RELATED ARTICLES

He or She? Remains Tell the Whole Tooth

News

Researchers have come up with a new way to estimate the biological sex of human skeletal remains based on protein traces from teeth.

READ MORE

Anti-Aging Protein Protects the Brain from the Immune System

News

The choroid plexus is a complex network of cells that produce cerebrospinal fluid, and form an important barrier between the CNS and the blood. A new study has set out to discover why it also contains vastly higher levels of the anti-aging protein klotho that any other brain region.

READ MORE

Synthetic Molecule Invades Double-stranded DNA

News

Researchers have developed a synthetic molecule that can recognize and bind to double-stranded DNA or RNA under normal physiological conditions. The molecule could provide a new platform for developing methods for the diagnosis and treatment of genetic conditions.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE